Search
for
Sort by
Research 901–930 of 1000+
- Metformin influence on hormone levels at birth, in PCOS mothers and their newborns
- Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome
- Epitestosterone—an endogenous antiandrogen?
- 7 Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women
- Binding of Steroid Hormones by the 105,000 x g Supernatant Fraction from Homogenates of Rat Skin and Variations during the Hair Cycle
- The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?
- Sex hormones and sarcopenia in older persons
- In vitro bioassays for androgens and their diagnostic applications
- Minoxidil increases 17β-hydroxysteroid dehydrogenase and 5α-reductase activity of cultured human dermal papilla cells from balding scalp
- Steroid Chemistry and Hormone Controls during the Hair Follicle Cycle
- The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty
- Hair Biology
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Rapid nongenomic modulation by neurosteroids of dendritic spines in the hippocampus: Androgen, oestrogen and corticosteroid
- The quantification of reproductive hormones in the hair of captive adult brown bears and their application as indicators of sex and reproductive state
- Androgenic Hormone Profile of Adult Women with Acne
- Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
- Caffeine improves barrier function in male skin
- Formulation and optimization of transfersome containing minoxidil and caffeine
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- Virilizing Adrenocortical Oncocytoma in a Child: A Case Report
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Understanding and Addressing Hair Disorders in Transgender Individuals
- A systematic review of antiandrogens and feminization in transgender women
- Androgens Induce Nongenomic Stimulation of Colonic Contractile Activity through Induction of Calcium Sensitization and Phosphorylation of LC20 and CPI-17
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*